Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)
Clinical trial NCT04144036 · COMPLETED
Trial details
- NCT number
- NCT04144036
- Sponsor
- Sameem M. Abedin, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2023-04-20
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.